Cargando…
Clinical Effects of Piribedil in Adjuvant Treatment of Parkinson’s Disease: A Meta-Analysis
Objective. To evaluate the clinical effects of piribedil in adjuvant treatment of Parkinson’s Disease (PD) by pooling previously openly published studies. Methods. The related electronic databases of Medline (1960~2017.5), Cochrane central register of controlled trials (CENTRAL), EMBASE (1980~2017.5...
Autores principales: | Peihua, Lu, Jianqin, Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter Open
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046618/ https://www.ncbi.nlm.nih.gov/pubmed/30019007 http://dx.doi.org/10.1515/med-2018-0041 |
Ejemplares similares
-
Pathological gambling in a patient on piribedil: A case report
por: Wang, Yingtan, et al.
Publicado: (2021) -
Hypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review
por: Zhang, Piao, et al.
Publicado: (2018) -
Treatment with Piribedil and Memantine Reduces Noise-Induced Loss of Inner Hair Cell Synaptic Ribbons
por: Altschuler, Richard A., et al.
Publicado: (2016) -
Dopamine D(2) receptor and β-arrestin 2 mediate Amyloid-β elevation induced by anti-parkinson’s disease drugs, levodopa and piribedil, in neuronal cells
por: Lu, Jing, et al.
Publicado: (2017) -
A meta-analysis of association between glutathione S-transferase M1 gene polymorphism and Parkinson’s disease susceptibility
por: Weikang, Chen, et al.
Publicado: (2016)